{
    "nct_id": "NCT04308304",
    "title": "A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Pharmacokinetics of MK-1942 Administered to Alzheimer's Disease Patients Receiving Donepezil Treatment.",
    "status": "COMPLETED",
    "last_update_time": "2024-08-13",
    "description_brief": "The study investigated the effects on safety and pharmacokinetics (PK) of MK-1942 and donepezil when co-administered to participants with Alzheimer's Disease with mild-to-moderate cognitive impairment stably treated with donepezil. The objectives of this study were to determine if the combination of MK-1942 with donepezil increases the incidence or severity of adverse events (AEs) previously reported for these agents alone, or results in unanticipated AEs in the patient population targeted for MK-1942 treatment. In addition, changes in the PK parameters of either MK-1942 or donepezil as a result of co-administration were assessed.",
    "description_detailed": "N/A",
    "phase": [
        "PHASE1"
    ],
    "study_type": "INTERVENTIONAL",
    "primary_purpose": "TREATMENT",
    "results": {
        "participantFlowModule": {
            "recruitmentDetails": "Male and female adult (\u226550 to \u226485 years of age) participants with Alzheimer's disease (AD) and mild-to-moderate cognitive impairment were enrolled at 4 study centers in the United States.",
            "groups": [
                {
                    "id": "FG000",
                    "title": "MK-1942 AD",
                    "description": "Participants with AD receive donepezil 10 mg to 15 mg once daily (QD), and MK-1942 twice daily (BID), for 28 days. Doses of MK-1942 were 8 mg (Week 1), 15 mg (Week 2), 30 mg (Week 3) and 50 mg (Week 4)."
                },
                {
                    "id": "FG001",
                    "title": "Placebo + Donepezil AD",
                    "description": "Participants with AD receive donepezil 10 mg to 15 mg QD, and placebo BID, for 28 days."
                }
            ],
            "periods": [
                {
                    "title": "Overall Study",
                    "milestones": [
                        {
                            "type": "STARTED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "22"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "5"
                                }
                            ]
                        },
                        {
                            "type": "COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "17"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "5"
                                }
                            ]
                        },
                        {
                            "type": "NOT COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "5"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "0"
                                }
                            ]
                        }
                    ],
                    "dropWithdraws": [
                        {
                            "type": "Withdrawal by Subject",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "4"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "0"
                                }
                            ]
                        },
                        {
                            "type": "Protocol Violation",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "1"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "0"
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "baselineCharacteristicsModule": {
            "groups": [
                {
                    "id": "BG000",
                    "title": "MK-1942 AD",
                    "description": "Participants with AD receive donepezil 10 mg to 15 mg once daily (QD), and MK-1942 twice daily (BID), for 28 days. Doses of MK-1942 were 8 mg (Week 1), 15 mg (Week 2), 30 mg (Week 3) and 50 mg (Week 4)."
                },
                {
                    "id": "BG001",
                    "title": "Placebo + Donepezil AD",
                    "description": "Participants with AD receive donepezil 10 mg to 15 mg QD, and placebo BID, for 28 days."
                },
                {
                    "id": "BG002",
                    "title": "Total",
                    "description": "Total of all reporting groups"
                }
            ],
            "denoms": [
                {
                    "units": "Participants",
                    "counts": [
                        {
                            "groupId": "BG000",
                            "value": "22"
                        },
                        {
                            "groupId": "BG001",
                            "value": "5"
                        },
                        {
                            "groupId": "BG002",
                            "value": "27"
                        }
                    ]
                }
            ],
            "measures": [
                {
                    "title": "Age, Continuous",
                    "paramType": "MEAN",
                    "dispersionType": "STANDARD_DEVIATION",
                    "unitOfMeasure": "years",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "69.1",
                                            "spread": "5.5"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "69.4",
                                            "spread": "2.6"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "69.2",
                                            "spread": "5.0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Sex: Female, Male",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "Female",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "10"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "2"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "12"
                                        }
                                    ]
                                },
                                {
                                    "title": "Male",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "12"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "3"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "15"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Ethnicity (NIH/OMB)",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "Hispanic or Latino",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "19"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "4"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "23"
                                        }
                                    ]
                                },
                                {
                                    "title": "Not Hispanic or Latino",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "2"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "3"
                                        }
                                    ]
                                },
                                {
                                    "title": "Unknown or Not Reported",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "1"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Race (NIH/OMB)",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "American Indian or Alaska Native",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Asian",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Native Hawaiian or Other Pacific Islander",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Black or African American",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "7"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "7"
                                        }
                                    ]
                                },
                                {
                                    "title": "White",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "15"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "5"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "20"
                                        }
                                    ]
                                },
                                {
                                    "title": "More than one race",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Unknown or Not Reported",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "outcomeMeasuresModule": {
            "outcomeMeasures": [
                {
                    "type": "PRIMARY",
                    "title": "Number of Participants With \u22651 Adverse Event (AE)",
                    "description": "An AE is any untoward medical occurrence in a clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention.",
                    "populationDescription": "All participants who received \u22651 dose of study treatment are included.",
                    "reportingStatus": "POSTED",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "timeFrame": "Up to Day 42",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "MK-1942 8 mg + Donepezil AD",
                            "description": "Participants with AD received MK-1942 8 mg + donepezil during Week 1."
                        },
                        {
                            "id": "OG001",
                            "title": "MK-1942 15 mg + Donepezil AD",
                            "description": "Participants with AD received MK-1942 15 mg + donepezil during Week 2."
                        },
                        {
                            "id": "OG002",
                            "title": "MK-1942 30 mg + Donepezil AD",
                            "description": "Participants with AD received MK-1942 30 mg + donepezil during Week 3."
                        },
                        {
                            "id": "OG003",
                            "title": "MK-1942 50 mg + Donepezil AD",
                            "description": "Participants with AD received MK-1942 50 mg + donepezil during Week 4."
                        },
                        {
                            "id": "OG004",
                            "title": "Placebo + Donepezil AD",
                            "description": "Participants with AD receive donepezil 10 mg to 15 mg QD, and placebo BID, for 28 days."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "22"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "19"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "15"
                                },
                                {
                                    "groupId": "OG003",
                                    "value": "15"
                                },
                                {
                                    "groupId": "OG004",
                                    "value": "5"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "13"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "4"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "4"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "5"
                                        },
                                        {
                                            "groupId": "OG004",
                                            "value": "4"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "PRIMARY",
                    "title": "Number of Participants Discontinuing From Study Therapy Due to an Adverse Event (AE)",
                    "description": "An AE is any untoward medical occurrence in a clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention.",
                    "populationDescription": "All participants who received \u22651 dose of study treatment are included.",
                    "reportingStatus": "POSTED",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "timeFrame": "Up to Day 28",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "MK-1942 8 mg AD",
                            "description": "Participants with AD received MK-1942 8 mg + donepezil during Week 1."
                        },
                        {
                            "id": "OG001",
                            "title": "MK-1942 15 mg AD",
                            "description": "Participants with AD received MK-1942 15 mg + donepezil during Week 2."
                        },
                        {
                            "id": "OG002",
                            "title": "MK-1942 30 mg AD",
                            "description": "Participants with AD received MK-1942 30 mg + donepezil during Week 3."
                        },
                        {
                            "id": "OG003",
                            "title": "MK-1942 50 mg AD",
                            "description": "Participants with AD received MK-1942 50 mg + donepezil during Week 4."
                        },
                        {
                            "id": "OG004",
                            "title": "Placebo AD",
                            "description": "Participants with AD receive donepezil 10 mg to 15 mg QD, and placebo BID, for 28 days."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "22"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "19"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "15"
                                },
                                {
                                    "groupId": "OG003",
                                    "value": "15"
                                },
                                {
                                    "groupId": "OG004",
                                    "value": "5"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG004",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "PRIMARY",
                    "title": "Number of Participants With Clinically Significant Abnormalities in 12-Lead Electrocardiogram (ECG) Findings",
                    "description": "The number of participants with clinically significant 12-lead ECGs is presented. Recordings were made throughout the study, with the participant in a semi-recumbent position having rested in this position for at least 10 minutes beforehand.",
                    "populationDescription": "All participants who received \u22651 dose of study treatment are included.",
                    "reportingStatus": "POSTED",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "timeFrame": "Up to Day 28",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "MK-1942 8 mg",
                            "description": "Participants received MK-1942 8 mg + donepezil during Week 1."
                        },
                        {
                            "id": "OG001",
                            "title": "MK-1942 15 mg",
                            "description": "Participants received MK-1942 15 mg + donepezil during Week 2."
                        },
                        {
                            "id": "OG002",
                            "title": "MK-1942 30 mg",
                            "description": "Participants received MK-1942 30 mg + donepezil during Week 3."
                        },
                        {
                            "id": "OG003",
                            "title": "MK-1942 50 mg",
                            "description": "Participants received MK-1942 50 mg + donepezil during Week 4."
                        },
                        {
                            "id": "OG004",
                            "title": "Placebo AD",
                            "description": "Participants with AD receive donepezil 10 mg to 15 mg QD, and placebo BID, for 28 days."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "22"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "19"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "15"
                                },
                                {
                                    "groupId": "OG003",
                                    "value": "15"
                                },
                                {
                                    "groupId": "OG004",
                                    "value": "5"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG004",
                                            "value": "1"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "PRIMARY",
                    "title": "Number of Participants With Abnormal (Impaired) Results on Targeted Neurological Exams",
                    "description": "The number of participants with abnormal (impaired) results on targeted neurological exams will be presented. The targeted neurological exam contains Modules 1, 2 and 5 of the general examination, focusing on arousal, cranial nerve function, and gait and will be administered several times throughout the treatment period starting on Day 1 up until Day 29. The number of participants with abnormal (impaired) results on targeted neurological exams will be reported. Each exam will be graded as Normal or Impaired with the abnormality described.",
                    "populationDescription": "All participants who received \u22651 dose of study treatment are included.",
                    "reportingStatus": "POSTED",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "timeFrame": "Up to 29 days",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "MK-1942 8 mg",
                            "description": "Participants received MK-1942 8 mg + donepezil during Week 1."
                        },
                        {
                            "id": "OG001",
                            "title": "MK-1942 15 mg",
                            "description": "Participants received MK-1942 15 mg + donepezil during Week 2."
                        },
                        {
                            "id": "OG002",
                            "title": "MK-1942 30 mg",
                            "description": "Participants received MK-1942 30 mg + donepezil during Week 3."
                        },
                        {
                            "id": "OG003",
                            "title": "MK-1942 50 mg",
                            "description": "Participants received MK-1942 50 mg + donepezil during Week 4."
                        },
                        {
                            "id": "OG004",
                            "title": "Placebo AD",
                            "description": "Participants with AD receive donepezil 10 mg to 15 mg QD, and placebo BID, for 28 days."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "22"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "19"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "15"
                                },
                                {
                                    "groupId": "OG003",
                                    "value": "15"
                                },
                                {
                                    "groupId": "OG004",
                                    "value": "5"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG004",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "PRIMARY",
                    "title": "Number of Participants Who Reported Suicidal Ideation and/or Behavior on Study Based on Responses to the Columbia Suicide Severity Rating Scale (C-SSRS)",
                    "description": "The number of participants with suicidality using the C-SSRS is presented. The C-SSR will be used in this study only for the purpose of safety monitoring by measuring the incidence of different types of suicidality categories during treatment. C-SSRS assessment will be based upon a clinician's interpretation of the participant's responses to the C-SSRS questions, not by a numbered scale. Suicidal ideation and/or behaviors identified on the C-SSRS may not be considered an adverse event, based on the investigator's judgment. Participants who report at least one occurrence of suicidal behavior or suicidal ideation will be counted as having experienced suicidality. Suicidal behavior includes suicide attempt, aborted attempt, interrupted attempt, or preparatory behavior. Suicidal ideation include a wish to die or active suicidal thought with or without method, intent or plan.",
                    "populationDescription": "All participants who received \u22651 dose of study treatment are included.",
                    "reportingStatus": "POSTED",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "timeFrame": "Up to 42 days",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "MK-1942 8 mg",
                            "description": "Participants received MK-1942 8 mg + donepezil during Week 1."
                        },
                        {
                            "id": "OG001",
                            "title": "MK-1942 15 mg",
                            "description": "Participants received MK-1942 15 mg + donepezil during Week 2."
                        },
                        {
                            "id": "OG002",
                            "title": "MK-1942 30 mg",
                            "description": "Participants received MK-1942 30 mg + donepezil during Week 3."
                        },
                        {
                            "id": "OG003",
                            "title": "MK-1942 50 mg",
                            "description": "Participants received MK-1942 50 mg + donepezil during Week 4."
                        },
                        {
                            "id": "OG004",
                            "title": "Placebo AD",
                            "description": "Participants with AD receive donepezil 10 mg to 15 mg QD, and placebo BID, for 28 days."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "22"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "19"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "15"
                                },
                                {
                                    "groupId": "OG003",
                                    "value": "15"
                                },
                                {
                                    "groupId": "OG004",
                                    "value": "5"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG004",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "PRIMARY",
                    "title": "Change From Baseline in Heart Rate (HR)",
                    "description": "The mean change from baseline in HR is presented. Change in HR was determined the first day of treatment with a new dose of MK-1942. A negative value indicates a decrease in HR relative to baseline, and a positive value indicates an increase.",
                    "populationDescription": "All participants who received \u22651 dose of study treatment are included.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "beats/min",
                    "timeFrame": "Baseline (Day -1) and Days 1, 8, 15, and 22: 2 hours postdose",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "MK-1942 8 mg",
                            "description": "Participants received MK-1942 8 mg + donepezil during Week 1."
                        },
                        {
                            "id": "OG001",
                            "title": "MK-1942 15 mg",
                            "description": "Participants received MK-1942 15 mg + donepezil during Week 2."
                        },
                        {
                            "id": "OG002",
                            "title": "MK-1942 30 mg",
                            "description": "Participants received MK-1942 30 mg + donepezil during Week 3."
                        },
                        {
                            "id": "OG003",
                            "title": "MK-1942 50 mg",
                            "description": "Participants received MK-1942 50 mg + donepezil during Week 4."
                        },
                        {
                            "id": "OG004",
                            "title": "Placebo AD",
                            "description": "Participants with AD receive donepezil 10 mg to 15 mg QD, and placebo BID, for 28 days."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "22"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "19"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "15"
                                },
                                {
                                    "groupId": "OG003",
                                    "value": "15"
                                },
                                {
                                    "groupId": "OG004",
                                    "value": "5"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-2.27",
                                            "spread": "1.25"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "2.56",
                                            "spread": "1.65"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "6.14",
                                            "spread": "2.27"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "0.21",
                                            "spread": "2.81"
                                        },
                                        {
                                            "groupId": "OG004",
                                            "value": "-4.53",
                                            "spread": "1.06"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "PRIMARY",
                    "title": "Change From Baseline in Systolic Blood Pressure (SBP)",
                    "description": "The mean change from baseline in SBP is presented. Change in SBP was determined the first day of treatment with a new dose of MK-1942. Negative values represent a decrease in SBP relative to baseline, and positive values represent an increase.",
                    "populationDescription": "All participants who received \u22651 dose of study treatment are included.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "mmHg",
                    "timeFrame": "Baseline (Day -1) and Days 1, 8, 15, and 22: 2 hours postdose",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "MK-1942 8 mg",
                            "description": "Participants received MK-1942 8 mg + donepezil during Week 1."
                        },
                        {
                            "id": "OG001",
                            "title": "MK-1942 15 mg",
                            "description": "Participants received MK-1942 15 mg + donepezil during Week 2."
                        },
                        {
                            "id": "OG002",
                            "title": "MK-1942 30 mg",
                            "description": "Participants received MK-1942 30 mg + donepezil during Week 3."
                        },
                        {
                            "id": "OG003",
                            "title": "MK-1942 50 mg",
                            "description": "Participants received MK-1942 50 mg + donepezil during Week 4."
                        },
                        {
                            "id": "OG004",
                            "title": "Placebo AD",
                            "description": "Participants with AD receive donepezil 10 mg to 15 mg QD, and placebo BID, for 28 days."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "22"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "19"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "15"
                                },
                                {
                                    "groupId": "OG003",
                                    "value": "15"
                                },
                                {
                                    "groupId": "OG004",
                                    "value": "5"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "2.48",
                                            "spread": "2.08"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.15",
                                            "spread": "2.59"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "0.88",
                                            "spread": "2.09"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "1.45",
                                            "spread": "2.19"
                                        },
                                        {
                                            "groupId": "OG004",
                                            "value": "5.93",
                                            "spread": "4.00"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "PRIMARY",
                    "title": "Mean Change From Baseline in Diastolic Blood Pressure (DBP)",
                    "description": "The mean change from baseline in DBP is presented. Change in DBP was determined the first day of treatment with a new dose of MK-1942. Negative values represent a decrease in DBP relative to baseline, and positive values represent an increase.",
                    "populationDescription": "All participants who received \u22651 dose of study treatment are included.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "mmHg",
                    "timeFrame": "Baseline (Day -1) and Days 1, 8, 15, and 22: 2 hours postdose",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "MK-1942 8 mg",
                            "description": "Participants received MK-1942 8 mg + donepezil during Week 1."
                        },
                        {
                            "id": "OG001",
                            "title": "MK-1942 15 mg",
                            "description": "Participants received MK-1942 15 mg + donepezil during Week 2."
                        },
                        {
                            "id": "OG002",
                            "title": "MK-1942 30 mg",
                            "description": "Participants received MK-1942 30 mg + donepezil during Week 3."
                        },
                        {
                            "id": "OG003",
                            "title": "MK-1942 50 mg",
                            "description": "Participants received MK-1942 50 mg + donepezil during Week 4."
                        },
                        {
                            "id": "OG004",
                            "title": "Placebo AD",
                            "description": "Participants with AD receive donepezil 10 mg to 15 mg QD, and placebo BID, for 28 days."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "22"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "19"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "15"
                                },
                                {
                                    "groupId": "OG003",
                                    "value": "15"
                                },
                                {
                                    "groupId": "OG004",
                                    "value": "5"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.95",
                                            "spread": "0.93"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0.56",
                                            "spread": "2.01"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "1.17",
                                            "spread": "1.51"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "0.10",
                                            "spread": "1.39"
                                        },
                                        {
                                            "groupId": "OG004",
                                            "value": "-1.73",
                                            "spread": "3.36"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "PRIMARY",
                    "title": "Number of Participants With Abnormal Clinical Chemistry Test Results Reported as Adverse Events",
                    "description": "An AE is any untoward medical occurrence in a clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention. The number of participants with abnormal chemistry-related AEs is reported.",
                    "populationDescription": "All participants who received \u22651 dose of study treatment are included.",
                    "reportingStatus": "POSTED",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "timeFrame": "Up to 42 days",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "MK-1942 8 mg",
                            "description": "Participants received MK-1942 8 mg + donepezil during Week 1."
                        },
                        {
                            "id": "OG001",
                            "title": "MK-1942 15 mg",
                            "description": "Participants received MK-1942 15 mg + donepezil during Week 2."
                        },
                        {
                            "id": "OG002",
                            "title": "MK-1942 30 mg",
                            "description": "Participants received MK-1942 30 mg + donepezil during Week 3."
                        },
                        {
                            "id": "OG003",
                            "title": "MK-1942 50 mg",
                            "description": "Participants received MK-1942 50 mg + donepezil during Week 4."
                        },
                        {
                            "id": "OG004",
                            "title": "Placebo AD",
                            "description": "Participants with AD receive donepezil 10 mg to 15 mg QD, and placebo BID, for 28 days."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "22"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "19"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "15"
                                },
                                {
                                    "groupId": "OG003",
                                    "value": "15"
                                },
                                {
                                    "groupId": "OG004",
                                    "value": "5"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "OG004",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "PRIMARY",
                    "title": "Number of Participants With Abnormal Clinical Hematology Test Results Reported as Adverse Events",
                    "description": "An AE is any untoward medical occurrence in a clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention. The number of participants with abnormal hematology-related AEs is reported.",
                    "populationDescription": "All participants who received \u22651 dose of study treatment are included.",
                    "reportingStatus": "POSTED",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "timeFrame": "Up to 42 days",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "MK-1942 8 mg",
                            "description": "Participants received MK-1942 8 mg + donepezil during Week 1."
                        },
                        {
                            "id": "OG001",
                            "title": "MK-1942 15 mg",
                            "description": "Participants received MK-1942 15 mg + donepezil during Week 2."
                        },
                        {
                            "id": "OG002",
                            "title": "MK-1942 30 mg",
                            "description": "Participants received MK-1942 30 mg + donepezil during Week 3."
                        },
                        {
                            "id": "OG003",
                            "title": "MK-1942 50 mg",
                            "description": "Participants received MK-1942 50 mg + donepezil during Week 4."
                        },
                        {
                            "id": "OG004",
                            "title": "Placebo AD",
                            "description": "Participants with AD receive donepezil 10 mg to 15 mg QD, and placebo BID, for 28 days."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "22"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "19"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "15"
                                },
                                {
                                    "groupId": "OG003",
                                    "value": "15"
                                },
                                {
                                    "groupId": "OG004",
                                    "value": "5"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG004",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "PRIMARY",
                    "title": "Number of Participants With Abnormal Urinalysis Results Reported as Adverse Events",
                    "description": "An AE is any untoward medical occurrence in a clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention. The number of participants with an abnormal urinalysis results AE is reported.",
                    "populationDescription": "All participants who received \u22651 dose of study treatment are included.",
                    "reportingStatus": "POSTED",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "timeFrame": "Up to 42 days",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "MK-1942 8 mg",
                            "description": "Participants received MK-1942 8 mg + donepezil during Week 1."
                        },
                        {
                            "id": "OG001",
                            "title": "MK-1942 15 mg",
                            "description": "Participants received MK-1942 15 mg + donepezil during Week 2."
                        },
                        {
                            "id": "OG002",
                            "title": "MK-1942 30 mg",
                            "description": "Participants received MK-1942 30 mg + donepezil during Week 3."
                        },
                        {
                            "id": "OG003",
                            "title": "MK-1942 50 mg",
                            "description": "Participants received MK-1942 50 mg + donepezil during Week 4."
                        },
                        {
                            "id": "OG004",
                            "title": "Placebo AD",
                            "description": "Participants with AD receive donepezil 10 mg to 15 mg QD, and placebo BID, for 28 days."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "22"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "19"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "15"
                                },
                                {
                                    "groupId": "OG003",
                                    "value": "15"
                                },
                                {
                                    "groupId": "OG004",
                                    "value": "5"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "10"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG004",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Area Under the Plasma Concentration-Time Curve (AUC) From Dosing to 12 Hours Postdose (AUC0-12) of MK-1942",
                    "description": "AUC0-12 is reported for the first day of treatment of each MK-1942 dose.",
                    "populationDescription": "A subset of treated participants who complied with the protocol sufficiently to ensure the data are likely to reflect the underlying scientific model, are included. In addition, healthy control participant data is from study MK-1942-004.",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "95% Confidence Interval",
                    "unitOfMeasure": "hr*nmol/L",
                    "timeFrame": "Days 1, 7, 14, and 21 (morning dose only): predose and 0.5, 1, 2, 3, 4, 6, and 12 hours postdose",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "MK-1942 8 mg + Donepezil AD",
                            "description": "Participants with AD received MK-1942 8 mg + donepezil during Week 1."
                        },
                        {
                            "id": "OG001",
                            "title": "MK-1942 15 mg + Donepezil AD",
                            "description": "Participants with AD received MK-1942 15 mg + donepezil during Week 2."
                        },
                        {
                            "id": "OG002",
                            "title": "MK-1942 30 mg + Donepezil AD",
                            "description": "Participants received MK-1942 30 mg + donepezil during Week 3."
                        },
                        {
                            "id": "OG003",
                            "title": "MK-1942 50 mg + Donepezil AD",
                            "description": "Participants received MK-1942 50 mg + donepezil during Week 4."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "18"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "17"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "15"
                                },
                                {
                                    "groupId": "OG003",
                                    "value": "15"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "1760",
                                            "lowerLimit": "1390",
                                            "upperLimit": "2240"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "3580",
                                            "lowerLimit": "2860",
                                            "upperLimit": "4490"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "6650",
                                            "lowerLimit": "5330",
                                            "upperLimit": "8280"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "11600",
                                            "lowerLimit": "9110",
                                            "upperLimit": "14700"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000"
                            ],
                            "groupDescription": "'MK-1942 Alone PK' are unpublished data from MK-1942-004",
                            "nonInferiorityType": "OTHER",
                            "nonInferiorityComment": "MK-1942 + Donepezil PK / MK-1942 Alone PK",
                            "paramType": "Geometric Mean Ratio (GMR)",
                            "paramValue": "0.69",
                            "ciPctValue": "90",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "0.55",
                            "ciUpperLimit": "0.86"
                        },
                        {
                            "groupIds": [
                                "OG001"
                            ],
                            "groupDescription": "'MK-1942 Alone PK' are unpublished data from MK-1942-004",
                            "nonInferiorityType": "OTHER",
                            "nonInferiorityComment": "MK-1942 + Donepezil PK / MK-1942 Alone PK",
                            "paramType": "GMR",
                            "paramValue": "0.66",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "0.53",
                            "ciUpperLimit": "0.82"
                        },
                        {
                            "groupIds": [
                                "OG002"
                            ],
                            "groupDescription": "'MK-1942 Alone PK' are unpublished data from MK-1942-004",
                            "nonInferiorityType": "OTHER",
                            "nonInferiorityComment": "MK-1942 + Donepezil PK / MK-1942 Alone PK",
                            "paramType": "GMR",
                            "paramValue": "0.74",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "0.55",
                            "ciUpperLimit": "1.00"
                        },
                        {
                            "groupIds": [
                                "OG003"
                            ],
                            "groupDescription": "'MK-1942 Alone PK' are unpublished data from MK-1942-004",
                            "nonInferiorityType": "OTHER",
                            "nonInferiorityComment": "MK-1942 + Donepezil PK / MK-1942 PK Alone",
                            "paramType": "GMR",
                            "paramValue": "0.77",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "0.56",
                            "ciUpperLimit": "1.05"
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "AUC From Dosing to 24 Hours Postdose (AUC0-24) of MK-1942",
                    "description": "AUC0-24 is reported for the first day of treatment of each MK-1942 dose. Due to twice daily dosing, AUC0-24 was calculated as \"AUC0-24 = AUC0-12 x 2\".",
                    "populationDescription": "A subset of treated participants who complied with the protocol sufficiently to ensure the data are likely to reflect the underlying scientific model, are included. In addition, healthy control participant data is from study MK-1942-004.",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "95% Confidence Interval",
                    "unitOfMeasure": "hr*nmol/L",
                    "timeFrame": "Days 1, 7, 14, and 21 (morning dose only): predose and 0.5, 1, 2, 3, 4, 6, and 12 hours postdose",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "MK-1942 8 mg + Donepezil AD",
                            "description": "Participants with AD received MK-1942 8 mg + donepezil during Week 1."
                        },
                        {
                            "id": "OG001",
                            "title": "MK-1942 15 mg + Donepezil AD",
                            "description": "Participants with AD received MK-1942 15 mg + donepezil during Week 2."
                        },
                        {
                            "id": "OG002",
                            "title": "MK-1942 30 mg + Donepezil AD",
                            "description": "Participants received MK-1942 30 mg + donepezil during Week 3."
                        },
                        {
                            "id": "OG003",
                            "title": "MK-1942 50 mg + Donepezil AD",
                            "description": "Participants received MK-1942 50 mg + donepezil during Week 4."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "18"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "17"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "15"
                                },
                                {
                                    "groupId": "OG003",
                                    "value": "15"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "3530",
                                            "lowerLimit": "2790",
                                            "upperLimit": "4470"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "7160",
                                            "lowerLimit": "5710",
                                            "upperLimit": "8970"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "13330",
                                            "lowerLimit": "10700",
                                            "upperLimit": "16600"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "23200",
                                            "lowerLimit": "18200",
                                            "upperLimit": "29500"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000"
                            ],
                            "groupDescription": "'MK-1942 Alone PK' are unpublished data from MK-1942-004",
                            "nonInferiorityType": "OTHER",
                            "nonInferiorityComment": "MK-1942 + Donepezil PK / MK-1942 Alone PK",
                            "paramType": "Geometric Mean Ratio (GMR)",
                            "paramValue": "0.69",
                            "ciPctValue": "90",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "0.55",
                            "ciUpperLimit": "0.86"
                        },
                        {
                            "groupIds": [
                                "OG001"
                            ],
                            "groupDescription": "'MK-1942 Alone PK' are unpublished data from MK-1942-004",
                            "nonInferiorityType": "OTHER",
                            "nonInferiorityComment": "MK-1942 + Donepezil PK / MK-1942 Alone PK",
                            "paramType": "GMR",
                            "paramValue": "0.66",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "0.53",
                            "ciUpperLimit": "0.82"
                        },
                        {
                            "groupIds": [
                                "OG002"
                            ],
                            "groupDescription": "'MK-1942 Alone PK' are unpublished data from MK-1942-004",
                            "nonInferiorityType": "OTHER",
                            "nonInferiorityComment": "MK-1942 + Donepezil PK / MK-1942 Alone PK",
                            "paramType": "GMR",
                            "paramValue": "0.74",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "0.55",
                            "ciUpperLimit": "1.00"
                        },
                        {
                            "groupIds": [
                                "OG003"
                            ],
                            "groupDescription": "'MK-1942 Alone PK' are unpublished data from MK-1942-004",
                            "nonInferiorityType": "OTHER",
                            "nonInferiorityComment": "MK-1942 + Donepezil PK / MK-1942 PK Alone",
                            "paramType": "GMR",
                            "paramValue": "0.77",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "0.56",
                            "ciUpperLimit": "1.05"
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Maximum Plasma Concentration (Cmax) of MK-1942",
                    "description": "Cmax is reported for the first day of treatment of each MK-1942 dose.",
                    "populationDescription": "A subset of treated participants who complied with the protocol sufficiently to ensure the data are likely to reflect the underlying scientific model, are included. In addition, healthy control participant data is from study MK-1942-004.",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "95% Confidence Interval",
                    "unitOfMeasure": "nmol/L",
                    "timeFrame": "Days 1, 7, 14, and 21 (morning dose only): predose and 0.5, 1, 2, 3, 4, 6, and 12 hours postdose",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "MK-1942 8 mg + Donepezil AD",
                            "description": "Participants with AD received MK-1942 8 mg + donepezil during Week 1."
                        },
                        {
                            "id": "OG001",
                            "title": "MK-1942 15 mg + Donepezil AD",
                            "description": "Participants with AD received MK-1942 15 mg + donepezil during Week 2."
                        },
                        {
                            "id": "OG002",
                            "title": "MK-1942 30 mg + Donepezil AD",
                            "description": "Participants received MK-1942 30 mg + donepezil during Week 3."
                        },
                        {
                            "id": "OG003",
                            "title": "MK-1942 50 mg + Donepezil AD",
                            "description": "Participants received MK-1942 50 mg + donepezil during Week 4."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "18"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "17"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "15"
                                },
                                {
                                    "groupId": "OG003",
                                    "value": "15"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "239",
                                            "lowerLimit": "184",
                                            "upperLimit": "310"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "477",
                                            "lowerLimit": "371",
                                            "upperLimit": "613"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "876",
                                            "lowerLimit": "731",
                                            "upperLimit": "1050"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "1360",
                                            "lowerLimit": "1080",
                                            "upperLimit": "1720"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000"
                            ],
                            "groupDescription": "'MK-1942 Alone PK' are unpublished data from MK-1942-004",
                            "nonInferiorityType": "OTHER",
                            "nonInferiorityComment": "MK-1942 + Donepezil PK / MK-1942 Alone PK",
                            "paramType": "Geometric Mean Ratio (GMR)",
                            "paramValue": "0.67",
                            "ciPctValue": "90",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "0.52",
                            "ciUpperLimit": "0.87"
                        },
                        {
                            "groupIds": [
                                "OG001"
                            ],
                            "groupDescription": "'MK-1942 Alone PK' are unpublished data from MK-1942-004",
                            "nonInferiorityType": "OTHER",
                            "nonInferiorityComment": "MK-1942 + Donepezil PK / MK-1942 Alone PK",
                            "paramType": "GMR",
                            "paramValue": "0.68",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "0.52",
                            "ciUpperLimit": "0.87"
                        },
                        {
                            "groupIds": [
                                "OG002"
                            ],
                            "groupDescription": "'MK-1942 Alone PK' are unpublished data from MK-1942-004",
                            "nonInferiorityType": "OTHER",
                            "nonInferiorityComment": "MK-1942 + Donepezil PK / MK-1942 Alone PK",
                            "paramType": "GMR",
                            "paramValue": "0.79",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "0.59",
                            "ciUpperLimit": "1.06"
                        },
                        {
                            "groupIds": [
                                "OG003"
                            ],
                            "groupDescription": "'MK-1942 Alone PK' are unpublished data from MK-1942-004",
                            "nonInferiorityType": "OTHER",
                            "nonInferiorityComment": "MK-1942 + Donepezil PK / MK-1942 PK Alone",
                            "paramType": "GMR",
                            "paramValue": "0.74",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "0.51",
                            "ciUpperLimit": "1.08"
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Trough Plasma Concentration (Ctrough) of MK-1942",
                    "description": "Ctrough is reported for the first day of treatment of each MK-1942 dose. Data from healthy elderly participants used for statistical analyses are unpublished findings from study MK-1942-004.",
                    "populationDescription": "A subset of treated participants who complied with the protocol sufficiently to ensure the data are likely to reflect the underlying scientific model, are included. In addition, healthy control participant data is from study MK-1942-004.",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "95% Confidence Interval",
                    "unitOfMeasure": "nmol/L",
                    "timeFrame": "Days 1, 7, 14, and 21 (morning dose only): predose and 0.5, 1, 2, 3, 4, 6, and 12 hours postdose",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "MK-1942 8 mg + Donepezil AD",
                            "description": "Participants with AD received MK-1942 8 mg + donepezil during Week 1."
                        },
                        {
                            "id": "OG001",
                            "title": "MK-1942 15 mg + Donepezil AD",
                            "description": "Participants with AD received MK-1942 15 mg + donepezil during Week 2."
                        },
                        {
                            "id": "OG002",
                            "title": "MK-1942 30 mg + Donepezil AD",
                            "description": "Participants received MK-1942 30 mg + donepezil during Week 3."
                        },
                        {
                            "id": "OG003",
                            "title": "MK-1942 50 mg + Donepezil AD",
                            "description": "Participants received MK-1942 50 mg + donepezil during Week 4."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "18"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "17"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "15"
                                },
                                {
                                    "groupId": "OG003",
                                    "value": "15"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "101",
                                            "lowerLimit": "79.7",
                                            "upperLimit": "127"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "228",
                                            "lowerLimit": "188",
                                            "upperLimit": "277"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "386",
                                            "lowerLimit": "282",
                                            "upperLimit": "527"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "693",
                                            "lowerLimit": "528",
                                            "upperLimit": "910"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000"
                            ],
                            "groupDescription": "'MK-1942 Alone PK' are unpublished data from MK-1942-004",
                            "nonInferiorityType": "OTHER",
                            "nonInferiorityComment": "MK-1942 + Donepezil PK / MK-1942 Alone PK",
                            "paramType": "Geometric Mean Ratio (GMR)",
                            "paramValue": "0.62",
                            "ciPctValue": "90",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "0.48",
                            "ciUpperLimit": "0.80"
                        },
                        {
                            "groupIds": [
                                "OG001"
                            ],
                            "groupDescription": "'MK-1942 Alone PK' are unpublished data from MK-1942-004",
                            "nonInferiorityType": "OTHER",
                            "nonInferiorityComment": "MK-1942 + Donepezil PK / MK-1942 Alone PK",
                            "paramType": "GMR",
                            "paramValue": "0.67",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "0.55",
                            "ciUpperLimit": "0.81"
                        },
                        {
                            "groupIds": [
                                "OG002"
                            ],
                            "groupDescription": "'MK-1942 Alone PK' are unpublished data from MK-1942-004",
                            "nonInferiorityType": "OTHER",
                            "nonInferiorityComment": "MK-1942 + Donepezil PK / MK-1942 Alone PK",
                            "paramType": "GMR",
                            "paramValue": "0.68",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "0.49",
                            "ciUpperLimit": "0.93"
                        },
                        {
                            "groupIds": [
                                "OG003"
                            ],
                            "groupDescription": "'MK-1942 Alone PK' are unpublished data from MK-1942-004",
                            "nonInferiorityType": "OTHER",
                            "nonInferiorityComment": "MK-1942 + Donepezil PK / MK-1942 PK Alone",
                            "paramType": "GMR",
                            "paramValue": "0.72",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "0.54",
                            "ciUpperLimit": "0.98"
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Time to Reach Maximum Plasma Concentration (Tmax) of MK-1942",
                    "description": "Tmax is reported for the first day of treatment of each MK-1942 dose.",
                    "populationDescription": "A subset of treated participants who complied with the protocol sufficiently to ensure the data are likely to reflect the underlying scientific model, are included. In addition, healthy control participant data is from study MK-1942-004.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEDIAN",
                    "dispersionType": "Full Range",
                    "unitOfMeasure": "Hours",
                    "timeFrame": "Days 1, 7, 14, and 21 (morning dose only): predose and 0.5, 1, 2, 3, 4, 6, and 12 hours postdose",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "MK-1942 8 mg + Donepezil AD",
                            "description": "Participants with AD received MK-1942 8 mg + donepezil during Week 1."
                        },
                        {
                            "id": "OG001",
                            "title": "MK-1942 15 mg + Donepezil AD",
                            "description": "Participants with AD received MK-1942 15 mg + donepezil during Week 2."
                        },
                        {
                            "id": "OG002",
                            "title": "MK-1942 30 mg + Donepezil AD",
                            "description": "Participants received MK-1942 30 mg + donepezil during Week 3."
                        },
                        {
                            "id": "OG003",
                            "title": "MK-1942 50 mg + Donepezil AD",
                            "description": "Participants received MK-1942 50 mg + donepezil during Week 4."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "18"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "17"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "15"
                                },
                                {
                                    "groupId": "OG003",
                                    "value": "15"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "1.97",
                                            "lowerLimit": "0.93",
                                            "upperLimit": "3.00"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "1.98",
                                            "lowerLimit": "0.43",
                                            "upperLimit": "3.00"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "2.00",
                                            "lowerLimit": "1.00",
                                            "upperLimit": "5.95"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "2.00",
                                            "lowerLimit": "1.93",
                                            "upperLimit": "3.08"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Apparent Terminal Plasma Half-Life (t\u00bd) of MK-1942",
                    "description": "t\u00bd is reported for MK-1942 50 mg.",
                    "populationDescription": "A subset of treated participants who complied with the protocol sufficiently to ensure the data are likely to reflect the underlying scientific model, are included. In addition, healthy control participant data is from study MK-1942-004.",
                    "reportingStatus": "POSTED",
                    "paramType": "GEOMETRIC_MEAN",
                    "dispersionType": "Geometric Coefficient of Variation",
                    "unitOfMeasure": "Hours",
                    "timeFrame": "Day 21 (morning dose only): predose and 0.5, 1, 2, 3, 4, 6, and 12 hours postdose",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "MK-1942 50 mg + Donepezil AD",
                            "description": "Participants received MK-1942 50 mg + donepezil during Week 4."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "15"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "26.7",
                                            "spread": "27.7"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Apparent Clearance at Steady-state (CLss/F) of MK-1942",
                    "description": "CLss/F is reported for MK-1942 50 mg.",
                    "populationDescription": "A subset of treated participants who complied with the protocol sufficiently to ensure the data are likely to reflect the underlying scientific model, are included. In addition, healthy control participant data is from study MK-1942-004.",
                    "reportingStatus": "POSTED",
                    "paramType": "GEOMETRIC_MEAN",
                    "dispersionType": "Geometric Coefficient of Variation",
                    "unitOfMeasure": "L/h",
                    "timeFrame": "Day 21 (morning dose only): predose and 0.5, 1, 2, 3, 4, 6, and 12 hours postdose",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "MK-1942 50 mg + Donepezil AD",
                            "description": "Participants received MK-1942 50 mg + donepezil during Week 4."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "15"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "11.7",
                                            "spread": "45.5"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Apparent Volume of Distribution at Steady State (Vzss/F) of MK-1942",
                    "description": "Vzss/F is reported for MK-1942 50 mg.",
                    "populationDescription": "A subset of treated participants who complied with the protocol sufficiently to ensure the data are likely to reflect the underlying scientific model, are included. In addition, healthy control participant data is from study MK-1942-004.",
                    "reportingStatus": "POSTED",
                    "paramType": "GEOMETRIC_MEAN",
                    "dispersionType": "Geometric Coefficient of Variation",
                    "unitOfMeasure": "Liters",
                    "timeFrame": "Day 21 (morning dose only): predose and 0.5, 1, 2, 3, 4, 6, and 12 hours postdose",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "MK-1942 50 mg + Donepezil AD",
                            "description": "Participants received MK-1942 50 mg + donepezil during Week 4."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "15"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "449",
                                            "spread": "41.1"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "AUC0-24 of Donepezil",
                    "description": "AUC0-24 is reported for donepezil 10 mg alone (Day -1) or with MK-1942 50 mg (Day 28). Due to twice daily dosing, AUC0-24 was calculated as \"AUC0-12 x 2\".",
                    "populationDescription": "A subset of treated participants who complied with the protocol sufficiently to ensure the data are likely to reflect the underlying scientific model, are included. The same participant's data are used for Day -1 and Day 28 when available.",
                    "reportingStatus": "POSTED",
                    "paramType": "GEOMETRIC_MEAN",
                    "dispersionType": "Geometric Coefficient of Variation",
                    "unitOfMeasure": "hr*ng/mL",
                    "timeFrame": "Days 1, 7, 14, and 21 (morning dose only): predose and 0.5, 1, 2, 3, 4, 6, and 12 hours postdose",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Donepezil Day -1",
                            "description": "Participants received donepezil 10 mg alone (Day -1) or with MK-1942 50 mg (Day 28)."
                        },
                        {
                            "id": "OG001",
                            "title": "Donepezil Day 28",
                            "description": "Participants received donepezil in combination with MK-1942 for 28 days."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "20"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "15"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "606",
                                            "spread": "66.4"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "919",
                                            "spread": "44.4"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "nonInferiorityType": "OTHER",
                            "nonInferiorityComment": "Donepezil Accumulation Ratio (Day 28/Day -1)",
                            "paramType": "Geometric mean",
                            "paramValue": "1.34",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "52.4"
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Cmax of Donepezil",
                    "description": "Cmax is reported for donepezil 10 mg alone (Day -1) or with MK-1942 50 mg (Day 28).",
                    "populationDescription": "A subset of treated participants who complied with the protocol sufficiently to ensure the data are likely to reflect the underlying scientific model, are included. The same participant's data are used for Day -1 and Day 28 when available.",
                    "reportingStatus": "POSTED",
                    "paramType": "GEOMETRIC_MEAN",
                    "dispersionType": "Geometric Coefficient of Variation",
                    "unitOfMeasure": "ng/mL",
                    "timeFrame": "Days 1, 7, 14, and 21 (morning dose only): predose and 0.5, 1, 2, 3, 4, 6, and 12 hours postdose",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Donepezil Day -1",
                            "description": "Participants received donepezil 10 mg alone (Day -1) or with MK-1942 50 mg (Day 28)."
                        },
                        {
                            "id": "OG001",
                            "title": "Donepezil Day 28",
                            "description": "Participants received donepezil in combination with MK-1942 for 28 days."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "20"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "15"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "37.9",
                                            "spread": "56.4"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "53.3",
                                            "spread": "42.2"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "nonInferiorityType": "OTHER",
                            "nonInferiorityComment": "Donepezil Accumulation Ratio (Day 28/Day -1)",
                            "paramType": "Geometric mean",
                            "paramValue": "1.22",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "52.4"
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Ctrough of Donepezil",
                    "description": "Ctrough is reported for donepezil 10 mg alone (Day -1) or with MK-1942 50 mg (Day 28).",
                    "populationDescription": "A subset of treated participants who complied with the protocol sufficiently to ensure the data are likely to reflect the underlying scientific model, are included. The same participant's data are used for Day -1 and Day 28 when available.",
                    "reportingStatus": "POSTED",
                    "paramType": "GEOMETRIC_MEAN",
                    "dispersionType": "Geometric Coefficient of Variation",
                    "unitOfMeasure": "ng/mL",
                    "timeFrame": "Days 1, 7, 14, and 21 (morning dose only): predose and 0.5, 1, 2, 3, 4, 6, and 12 hours postdose",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Donepezil Day -1",
                            "description": "Participants received donepezil 10 mg alone (Day -1) or with MK-1942 50 mg (Day 28)."
                        },
                        {
                            "id": "OG001",
                            "title": "Donepezil Day 28",
                            "description": "Participants received donepezil in combination with MK-1942 for 28 days."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "20"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "15"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "20.1",
                                            "spread": "72.7"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "31.8",
                                            "spread": "52.5"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "nonInferiorityType": "OTHER",
                            "nonInferiorityComment": "Donepezil Accumulation Ratio (Day 28/Day -1)",
                            "paramType": "Geometric mean",
                            "paramValue": "1.46",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "60.8"
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Tmax of Donepezil",
                    "description": "Tmax is reported for donepezil 10 mg alone (Day -1) or with MK-1942 50 mg (Day 28).",
                    "populationDescription": "A subset of treated participants who complied with the protocol sufficiently to ensure the data are likely to reflect the underlying scientific model, are included. The same participant's data are used for Day -1 and Day 28 when available.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEDIAN",
                    "dispersionType": "Full Range",
                    "unitOfMeasure": "Hours",
                    "timeFrame": "Days 1, 7, 14, and 21 (morning dose only): predose and 0.5, 1, 2, 3, 4, 6, and 12 hours postdose",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Donepezil Day -1",
                            "description": "Participants received donepezil 10 mg alone (Day -1) or with MK-1942 50 mg (Day 28)."
                        },
                        {
                            "id": "OG001",
                            "title": "Donepezil Day 28",
                            "description": "Participants received donepezil in combination with MK-1942 for 28 days."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "20"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "15"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "2.05",
                                            "lowerLimit": "0.00",
                                            "upperLimit": "4.00"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "2.03",
                                            "lowerLimit": "1.00",
                                            "upperLimit": "3.95"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "adverseEventsModule": {
            "frequencyThreshold": "0",
            "timeFrame": "Up to 42 days",
            "description": "All participants who received \u22651 dose of study treatment are included. Safety is reported according to MK-1942 dose or placebo treatment received.",
            "eventGroups": [
                {
                    "id": "EG000",
                    "title": "MK-1942 8 mg BID 7 Days",
                    "description": "Participants received MK-1942 8 mg + donepezil during Week 1.",
                    "deathsNumAffected": 0,
                    "deathsNumAtRisk": 22,
                    "seriousNumAffected": 0,
                    "seriousNumAtRisk": 22,
                    "otherNumAffected": 13,
                    "otherNumAtRisk": 22
                },
                {
                    "id": "EG001",
                    "title": "MK-1942 15 mg BID 7 Days",
                    "description": "Participants received MK-1942 15 mg + donepezil during Week 2.",
                    "deathsNumAffected": 0,
                    "deathsNumAtRisk": 19,
                    "seriousNumAffected": 0,
                    "seriousNumAtRisk": 19,
                    "otherNumAffected": 4,
                    "otherNumAtRisk": 19
                },
                {
                    "id": "EG002",
                    "title": "MK-1942 30 mg Bid 7D",
                    "description": "Participants received MK-1942 30 mg + donepezil during Week 3.",
                    "deathsNumAffected": 0,
                    "deathsNumAtRisk": 15,
                    "seriousNumAffected": 0,
                    "seriousNumAtRisk": 15,
                    "otherNumAffected": 4,
                    "otherNumAtRisk": 15
                },
                {
                    "id": "EG003",
                    "title": "MK-1942 50 mg BID & Days",
                    "description": "Participants received MK-1942 50 mg + donepezil during Week 4.",
                    "deathsNumAffected": 0,
                    "deathsNumAtRisk": 15,
                    "seriousNumAffected": 0,
                    "seriousNumAtRisk": 15,
                    "otherNumAffected": 5,
                    "otherNumAtRisk": 15
                },
                {
                    "id": "EG004",
                    "title": "MK-1942 Total",
                    "description": "Participants received MK-1924 8 mg, 15 mg, 30 mg, and 50 mg during Weeks 1, 2, 3, and 4, respectively.",
                    "deathsNumAffected": 0,
                    "deathsNumAtRisk": 22,
                    "seriousNumAffected": 0,
                    "seriousNumAtRisk": 22,
                    "otherNumAffected": 18,
                    "otherNumAtRisk": 22
                },
                {
                    "id": "EG005",
                    "title": "Placebo Bid",
                    "description": "Participants received placebo + donepezil for 7 days.",
                    "deathsNumAffected": 0,
                    "deathsNumAtRisk": 5,
                    "seriousNumAffected": 0,
                    "seriousNumAtRisk": 5,
                    "otherNumAffected": 4,
                    "otherNumAtRisk": 5
                }
            ],
            "otherEvents": [
                {
                    "term": "Scleral hyperaemia",
                    "organSystem": "Eye disorders",
                    "sourceVocabulary": "MedDRA 25.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 19
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG004",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG005",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Scleritis",
                    "organSystem": "Eye disorders",
                    "sourceVocabulary": "MedDRA 25.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 19
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG004",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG005",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Vision blurred",
                    "organSystem": "Eye disorders",
                    "sourceVocabulary": "MedDRA 25.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 19
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG004",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG005",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Anal incontinence",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA 25.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 19
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG004",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG005",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Constipation",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA 25.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 19
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG004",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG005",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Diarrhoea",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA 25.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 19
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG004",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG005",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Dyspepsia",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA 25.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 19
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG004",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG005",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Nausea",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA 25.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 5,
                            "numAffected": 5,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 19
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 3,
                            "numAffected": 2,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG004",
                            "numEvents": 9,
                            "numAffected": 7,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG005",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Vomiting",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA 25.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 2,
                            "numAffected": 1,
                            "numAtRisk": 19
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG004",
                            "numEvents": 4,
                            "numAffected": 2,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG005",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Gait disturbance",
                    "organSystem": "General disorders",
                    "sourceVocabulary": "MedDRA 25.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 19
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG004",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG005",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Medical device site injury",
                    "organSystem": "General disorders",
                    "sourceVocabulary": "MedDRA 25.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 19
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG004",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG005",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Oedema peripheral",
                    "organSystem": "General disorders",
                    "sourceVocabulary": "MedDRA 25.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 19
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG004",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG005",
                            "numEvents": 2,
                            "numAffected": 1,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Vessel puncture site bruise",
                    "organSystem": "General disorders",
                    "sourceVocabulary": "MedDRA 25.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 19
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG004",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG005",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Upper respiratory tract infection",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 25.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 19
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG004",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG005",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Skin laceration",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 25.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 19
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG004",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG005",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Alanine aminotransferase increased",
                    "organSystem": "Investigations",
                    "sourceVocabulary": "MedDRA 25.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 19
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG004",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG005",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Aspartate aminotransferase increased",
                    "organSystem": "Investigations",
                    "sourceVocabulary": "MedDRA 25.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 19
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG004",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG005",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Blood sodium decreased",
                    "organSystem": "Investigations",
                    "sourceVocabulary": "MedDRA 25.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 19
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG004",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG005",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Electrocardiogram QT prolonged",
                    "organSystem": "Investigations",
                    "sourceVocabulary": "MedDRA 25.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 19
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG004",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG005",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Electrocardiogram T wave biphasic",
                    "organSystem": "Investigations",
                    "sourceVocabulary": "MedDRA 25.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 19
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG004",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG005",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Haemoglobin decreased",
                    "organSystem": "Investigations",
                    "sourceVocabulary": "MedDRA 25.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 19
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG004",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG005",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Decreased appetite",
                    "organSystem": "Metabolism and nutrition disorders",
                    "sourceVocabulary": "MedDRA 25.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 19
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG004",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG005",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Back pain",
                    "organSystem": "Musculoskeletal and connective tissue disorders",
                    "sourceVocabulary": "MedDRA 25.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 19
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG004",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG005",
                            "numEvents": 2,
                            "numAffected": 1,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Myalgia",
                    "organSystem": "Musculoskeletal and connective tissue disorders",
                    "sourceVocabulary": "MedDRA 25.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 19
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG004",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG005",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Pain in extremity",
                    "organSystem": "Musculoskeletal and connective tissue disorders",
                    "sourceVocabulary": "MedDRA 25.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 19
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG004",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG005",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Balance disorder",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 25.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 19
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG004",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG005",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Dizziness",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 25.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 3,
                            "numAffected": 3,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 19
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG004",
                            "numEvents": 5,
                            "numAffected": 5,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG005",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Dizziness postural",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 25.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 19
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG004",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG005",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Dystonia",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 25.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 19
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG004",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG005",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Headache",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 25.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 19
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG004",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG005",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Nystagmus",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 25.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 19
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 2,
                            "numAffected": 1,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG004",
                            "numEvents": 4,
                            "numAffected": 3,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG005",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Anxiety",
                    "organSystem": "Psychiatric disorders",
                    "sourceVocabulary": "MedDRA 25.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 19
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG004",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG005",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Nasal congestion",
                    "organSystem": "Respiratory, thoracic and mediastinal disorders",
                    "sourceVocabulary": "MedDRA 25.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 19
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG004",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG005",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Dermatitis contact",
                    "organSystem": "Skin and subcutaneous tissue disorders",
                    "sourceVocabulary": "MedDRA 25.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 19
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG004",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG005",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Pruritus",
                    "organSystem": "Skin and subcutaneous tissue disorders",
                    "sourceVocabulary": "MedDRA 25.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 19
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG004",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG005",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Hypertension",
                    "organSystem": "Vascular disorders",
                    "sourceVocabulary": "MedDRA 25.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 19
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 15
                        },
                        {
                            "groupId": "EG004",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        },
                        {
                            "groupId": "EG005",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 5
                        }
                    ]
                }
            ]
        },
        "moreInfoModule": {
            "certainAgreement": {
                "piSponsorEmployee": false,
                "restrictionType": "OTHER",
                "restrictiveAgreement": true,
                "otherDetails": "If publication activity is not directed by the Sponsor, the investigator agrees to submit all manuscripts or abstracts to the Sponsor before submission."
            },
            "pointOfContact": {
                "title": "Senior Vice President, Global Clinical Development",
                "organization": "Merck Sharp & Dohme LLC",
                "email": "ClinicalTrialsDisclosure@merck.com",
                "phone": "1-800-672-6372"
            }
        }
    },
    "target_category": "cognitive enhancer",
    "drug": [
        "MK-1942 (small-molecule, Merck)",
        "donepezil (acetylcholinesterase inhibitor)"
    ],
    "placebo": [
        "placebo (to MK-1942)"
    ],
    "explanation_target": [
        "Reason: The trial tests MK-1942 co\u2011administered with donepezil in people with mild\u2011to\u2011moderate Alzheimer\u2019s disease to assess safety and pharmacokinetics; the program description and trial listing identify MK-1942 as a small\u2011molecule investigational drug (target not disclosed). \ue200cite\ue202turn0search1\ue202turn0search0\ue201",
        "Act: Key facts extracted \u2014 MK-1942 is a Merck small molecule; the cited Phase 1 trial (NCT04308304) evaluated safety/PK of MK-1942 given with donepezil in 27 AD patients. Later Phase 2 plans used ADAS\u2011Cog as a primary outcome, indicating an intent to measure symptomatic cognitive benefit. \ue200cite\ue202turn0search1\ue202turn0search7\ue202turn0search0\ue201",
        "Ambiguity noted: The molecular target of MK-1942 was not disclosed in public sources, so it cannot be confidently classified as a small molecule that specifically targets AD pathology (e.g., amyloid or tau). ALZFORUM and trial registries list it as a small molecule with an unknown target. \ue200cite\ue202turn0search0\ue202turn0search1\ue201",
        "Reflect: Given (a) MK-1942 is a small molecule with unknown molecular target and (b) the development program included symptomatic cognitive endpoints (ADAS\u2011Cog) and add\u2011on use with donepezil, the most appropriate category is 'cognitive enhancer' (drug intended to improve cognitive function symptomatically rather than a biologic or clearly pathology\u2011targeted disease\u2011modifying agent). If later evidence showed MK-1942 specifically targets amyloid, tau, or another disease pathway, the classification should be revised to 'disease-targeted small molecule'. \ue200cite\ue202turn0search0\ue202turn0search1\ue201",
        "Additional context / search results: ALZFORUM overview for MK\u20111942 (small\u2011molecule; target undisclosed; program later discontinued). \ue200cite\ue202turn0search0\ue201",
        "Clinical trial registry/report for NCT04308304 (MK\u20111942/Donepezil interactions; Phase 1 safety/PK; 27 participants; details on dosing and PK outcomes). \ue200cite\ue202turn0search1\ue202turn0search7\ue201",
        "Program status note: Public reports indicate Merck later terminated Phase 2 MK\u20111942 studies due to liver\u2011safety signals; this does not change the symptomatic/cognitive orientation of the planned AD efficacy endpoints but is relevant to program context. \ue200cite\ue202turn0search5\ue202turn0search0\ue201"
    ],
    "agent_type": "S) Unknown Target",
    "explanation_agent": [
        "Reason: The trial tests MK-1942 (a Merck small-molecule investigational drug) co\u2011administered with donepezil to assess safety and pharmacokinetics in people with mild\u2011to\u2011moderate AD, but public sources list MK-1942's molecular target as undisclosed \u2014 therefore the mechanism cannot be mapped to a specific CADRO biology category. \ue200cite\ue202turn0search0\ue202turn0search1\ue201",
        "Act: Key extracted facts \u2014 MK-1942 is a Merck small molecule; the Phase 1 interaction/safety/PK study (NCT04308304) enrolled 27 AD participants on stable donepezil and tested escalating MK-1942 doses vs placebo. Subsequent development plans included a Phase 2 adjunct study (ADAS\u2011Cog as an efficacy endpoint) before the program was later discontinued. These facts come from clinical-trial registries and ALZFORUM. \ue200cite\ue202turn0search1\ue202turn0search0\ue202turn0search4\ue201",
        "Ambiguity noted: Multiple authoritative sources explicitly state MK-1942's target/mechanism was not disclosed publicly (so it cannot confidently be classified under CADRO categories like Amyloid, Tau, Neurotransmitter Receptors, etc.). Because the investigational molecule's target is unknown, assigning a pathology- or pathway-specific CADRO class would be speculative. \ue200cite\ue202turn0search0\ue202turn0search2\ue201",
        "Reflect: Given the absence of a disclosed molecular target and that the development program treated MK-1942 as a symptomatic adjunct (cognitive-enhancer orientation) rather than a clearly disease-modifying agent, the most appropriate CADRO classification for this trial is S) Unknown Target. If Merck or other sources later disclose a defined biological target or pathway for MK-1942, the classification should be revisited and changed to the specific CADRO category that matches that target. \ue200cite\ue202turn0search0\ue202turn0search1\ue201",
        "Web search results referenced: (1) ALZFORUM overview for MK-1942 \u2014 small molecule; target undisclosed; program discontinued. \ue200cite\ue202turn0search0\ue201 (2) Clinical trial record / results for NCT04308304 (MK-1942 + donepezil; Phase 1 safety/PK; 27 participants). \ue200cite\ue202turn0search1\ue201 (3) ICHGCP/clinical-trial registry mirror with study metadata and updates. \ue200cite\ue202turn0search2\ue201 (4) Trial listings/phase-2 study location details (trial aggregator). \ue200cite\ue202turn0search4\ue201 (5) Community/trial summary entry (SmartPatients). \ue200cite\ue202turn0search3\ue201"
    ]
}